Overview Fluvastatin Versus Hepatitis C Virus Status: Completed Trial end date: 2007-09-01 Target enrollment: Participant gender: Summary This is a dose finding and efficacy trial for fluvastatin versus hepatitis C. Phase: N/A Details Lead Sponsor: Bader, Ted, M.D.Collaborators: US Department of Veterans AffairsVA Office of Research and DevelopmentTreatments: Fluvastatin